Trulieve Cannabis Corp. (TRLV)
NYSE: TRLV · Real-Time Price · USD
10.28
-0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM EDT
9.99
-0.29 (-2.80%)
After-hours: Oct 30, 2026, 4:14 PM EDT
Trulieve Cannabis Market Cap
Trulieve Cannabis has a market cap or net worth of $1.98 billion as of October 30, 2026. It is the 6,473rd most valuable company in the world and the 1,763rd biggest in the United States.
Market Cap
1.98B
Enterprise Value
2.23B
1-Year Change
n/a
Global Rank
Country Rank
#1,763 United States
Category
ChartMarket Cap Chart
Since June 10, 2026, Trulieve Cannabis's market cap has decreased from $2.21B to $1.98B, a decrease of -10.49%. That is a compound annual growth rate of -24.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.98B | -3.02% |
| Oct 29, 2026 | 2.04B | -0.19% |
| Oct 28, 2026 | 2.05B | -0.47% |
| Oct 27, 2026 | 2.05B | -1.39% |
| Oct 26, 2026 | 2.08B | 3.84% |
| Oct 23, 2026 | 2.01B | -4.58% |
| Oct 22, 2026 | 2.10B | -0.73% |
| Oct 21, 2026 | 2.12B | 1.94% |
| Oct 20, 2026 | 2.08B | 4.96% |
| Oct 19, 2026 | 1.98B | 2.70% |
| Oct 16, 2026 | 1.93B | -2.81% |
| Oct 15, 2026 | 1.98B | 3.31% |
| Oct 14, 2026 | 1.92B | -1.38% |
| Oct 13, 2026 | 1.95B | -2.70% |
| Oct 12, 2026 | 2.00B | -2.62% |
| Oct 9, 2026 | 2.05B | 2.89% |
| Oct 8, 2026 | 2.00B | -3.81% |
| Oct 7, 2026 | 2.08B | 1.22% |
| Oct 6, 2026 | 2.05B | - |
| Oct 5, 2026 | 2.05B | -0.65% |
| Oct 2, 2026 | 2.06B | -1.38% |
| Oct 1, 2026 | 2.09B | -0.28% |
| Sep 30, 2026 | 2.10B | -12.16% |
| Sep 29, 2026 | 2.39B | 0.56% |
| Sep 28, 2026 | 2.38B | 1.07% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.41B |
| Supernus Pharmaceuticals | 2.38B |
| Bausch Health Companies | 2.36B |
| Prestige Consumer Healthcare | 2.25B |
| Perrigo Company | 2.22B |
| BioCryst Pharmaceuticals | 2.07B |
| Xeris Biopharma Holdings | 1.91B |
| Alvotech | 1.70B |